Skip to main content

Octagon Capital Advisors LP

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1839435 NEW YORK, NY

Position in TSHA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$39,603,802
-$9,125,708 QoQ
Shares Held
8,859,911
0.0% QoQ
Ownership
3.08%
of shares outstanding
% of Portfolio
4.38%
of 13F equity value
Holder Rank
#11
of 190 holders
Holding Since
Dec 2020
13 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Octagon Capital Advisors LP holds $869,736,107 across 27 Biotechnology names. TSHA ranks #7 (4.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 TSHA
Taysha Gene Therapies, Inc.
This page
8,859,911 $39,603,802

All Filings in TSHA

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $39,603,802 8,859,911
2025-12-31 $48,729,510 8,859,911
2025-09-30 $29,650,725 9,067,500
2025-06-30 $29,088,675 12,592,500
2025-03-31 $14,873,000 10,700,000
2024-12-31 $18,078,500 10,450,000
2024-12-31 $18,078,500 10,450,000
2024-09-30 $9,190,166 4,572,222
2024-06-30 $10,241,777 4,572,222
2024-03-31 $8,696,100 3,030,000
2023-09-30 $8,777,778 2,777,778
2021-06-30 $6,793,328 320,440
2021-03-31 $6,504,932 320,440
2020-12-31 $8,504,477 320,440